List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 872 studies with search of:   "Paraproteinemias"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
21 Completed Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: carmustine;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: dexamethasone;   Drug: etoposide;   Drug: gemcitabine hydrochloride;   Drug: melphalan;   Drug: paclitaxel;   Procedure: bone marrow ablation with stem cell support;   Procedure: peripheral blood stem cell transplantation
22 Recruiting Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer
Conditions: Graft Versus Host Disease;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Drug: mycophenolate mofetil;   Drug: sirolimus;   Drug: tacrolimus
23 Recruiting Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: lenalidomide;   Drug: placebo
24 Completed The Effect of Epoetin Alfa on the Anemia of Patients With Multiple Myeloma
Conditions: Anemia;   Multiple Myeloma
Intervention: Drug: epoetin alfa
25 Recruiting Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation
Conditions: Cancer-Related Problem/Condition;   Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Procedure: psychosocial assessment and care;   Procedure: quality-of-life assessment
26 Recruiting Bortezomib and Dexamethasone in Treating Patients With Multiple Myeloma That Has Relapsed or Has Not Responded to Treatment
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: bortezomib;   Drug: dexamethasone
27 Recruiting Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
Conditions: Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes
Interventions: Drug: anti-thymocyte globulin;   Drug: busulfan;   Drug: fludarabine phosphate;   Drug: methotrexate;   Drug: sargramostim;   Drug: tacrolimus;   Drug: therapeutic allogeneic lymphocytes;   Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation;   Procedure: peripheral blood stem cell transplantation
28 Suspended Bortezomib, Arsenic Trioxide, and Melphalan in Treating Patients Undergoing an Autologous Stem Cell Transplant For Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: arsenic trioxide;   Drug: bortezomib;   Drug: melphalan;   Procedure: autologous hematopoietic stem cell transplantation
29 Recruiting High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors
Conditions: Childhood Germ Cell Tumor;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Neuroblastoma;   Testicular Germ Cell Tumor;   Unspecified Adult Solid Tumor, Protocol Specific;   Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Drug: busulfan;   Drug: carboplatin;   Drug: carmustine;   Drug: cyclophosphamide;   Drug: etoposide;   Drug: melphalan;   Drug: thiotepa;   Procedure: total-body irradiation
30 Recruiting Safety and Dose Study of GRN163L and Velcade to Treat Patients With Refractory or Relapsed Myeloma
Condition: Multiple Myeloma
Intervention: Drug: GRN163L
31 Recruiting Obatoclax and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: bortezomib;   Drug: obatoclax mesylate
32 Recruiting Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases
Conditions: Cancer-Related Problem/Condition;   Chronic Myeloproliferative Disorders;   Graft Versus Host Disease;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases;   Neuroblastoma
Interventions: Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: immunological diagnostic method;   Procedure: immunosuppressive therapy
33 Recruiting Study of Fluphenazine in Relapsed or Relapsed-and-Refractory Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Fluphenazine HCl
34 Completed Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome
Conditions: Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes
Interventions: Drug: busulfan;   Drug: cyclophosphamide;   Drug: cytarabine;   Procedure: allogeneic bone marrow transplantation
35 Completed Tocladesine in Treating Patients With Recurrent or Refractory Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Intervention: Drug: tocladesine
36 Active, not recruiting Dexamethasone With or Without Oblimersen in Treating Patients With Relapsed or Refractory Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: dexamethasone;   Drug: oblimersen
37 Completed Dexamethasone or Dexamethasone in Combination With Thalidomide as Salvage Therapy
Condition: Multiple Myeloma
Interventions: Drug: Thalidomide;   Drug: Dexamethasone
38 Active, not recruiting T-Cell Depletion, Donor Stem Cell Transplant, and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases
Conditions: Cancer-Related Problem/Condition;   Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Precancerous/Nonmalignant Condition
Interventions: Drug: cyclophosphamide;   Drug: tacrolimus;   Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: peripheral blood lymphocyte therapy;   Procedure: peripheral blood stem cell transplantation;   Procedure: total-body irradiation
39 Active, not recruiting This is a Study to Determine the Effect and Safety of an Oral Janus Kinase 2 (JAK2)-Inhibitor in Patients With Multiple Myeloma
Conditions: Relapsed Multiple Myeloma;   Refractory Multiple Myeloma;   Multiple Myeloma
Intervention: Drug: INCB018424
40 Recruiting Trial of Romidepsin and Bortezomib for Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Romidepsin, Bortezomib

Previous Page (1-20) Studies Shown (21-40) Next (41-60)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services